Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Glaucoma > Is sleep dysregulation linked to glaucoma?
  • Glaucoma

Is sleep dysregulation linked to glaucoma?

Ophthalmology 360

Abdelrahman Elhusseiny, MD, of Bascom Palmer Eye Institute, talks about the affect of circadian dysregulation on intraocular pressure. He presents a study from AAO 2025 that found a link between sleep dysregulation and glaucoma.

Abdelrahman Elhusseiny, MD:

Hi, I’m Abdelrahman Elhusseiny from Bascom Palmer and the University of Arkansas. It’s a pleasure to present our work on the association between circadian rhythm, sleep disorders, and the risk of open-angle glaucoma and ocular hypertension.

There is growing evidence that circadian dysregulation can affect intraocular pressure, retina ganglion cell, and ocular perfusion, all of which are involved in glaucoma pathogenesis. Based on that, we conducted our retrospective, multicentric database study to evaluate such kind of association. We used TriNetX database including 68 healthcare organizations in the States, and we identified patients with circadian rhythm sleep disorders using ICD-10 code and compared them to matched controls for patients who had polysomnography and was not diagnosed with any sleep disorder.

After propensity score matching of baseline characteristics, including demographic factors, systemic comorbidities, and medications, we found that patients with circadian rhythm sleep disorder have significantly increased risk of open-angle glaucoma at 1, 3, and 5 years following the diagnosis of the sleep disorder. The increased risk was approximately about threefold.

Interestingly, that risk was confined only to patients who did not use melatonin. For patients who use melatonin, the risk was similar to that of the healthy controls. Regarding ocular hypertension, there was no significant difference between any of the groups at any time point in the risk of developing ocular hypertension.

In summary, our study showed that circadian dysregulation may be a risk factor for developing glaucoma and melatonin may be protective for these patients. Thank you.

Share

Related Content

  • The Interventional Glaucoma Project

Improving Patient Experience and Practice Workflow With an Interventional Glaucoma Approach

  • The Interventional Glaucoma Project

Data-Driven Focus on Interventional Glaucoma Care

  • Conference Roundup

Cryopreserved amniotic membrane significantly improves ocular surface integrity in patients with severe keratoconjunctivitis sicca and neurotrophic keratopathy

  • Conference Roundup

CAM360 with a collagen shield provides rapid epithelial healing with better tolerability and safety than when used with bandage contact lenses

  • Conference Roundup

Enhanced monofocal IOLs provide better intermediate vision with no rings or dysphotopsia

  • Conference Roundup

Phase 1/2 CLARA study shows AURN001 improves BCVA compared with standard of care for corneal endothelial dysfunction

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon